Exact Mass: 610.0497

Exact Mass Matches: 610.0497

Found 45 metabolites which its exact mass value is equals to given mass value 610.0497, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(-)-Epigallocatechin 3,3'-di-gallate

(2R,3R)-2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


(-)-Epigallocatechin 3,3-di-gallate is found in tea. (-)-Epigallocatechin 3,3-di-gallate is isolated from green tea (Thea sinensis). Isolated from green tea (Thea sinensis). Epigallocatechin 3,3-digallate is found in tea.

   

(-)-Epigallocatechin 3,5-di-gallate

(2R,3R)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


(-)-Epigallocatechin 3,5-di-gallate is found in tea. (-)-Epigallocatechin 3,5-di-gallate is isolated from tea (Thea sinensis). Isolated from tea (Thea sinensis). Epigallocatechin 3,5-digallate is found in tea.

   

(-)-Epigallocatechin 3,4'-di-gallate

(2R,3R)-2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


(-)-Epigallocatechin 3,4-di-gallate is found in tea. (-)-Epigallocatechin 3,4-di-gallate is isolated from tea (Thea sinensis). Isolated from tea (Thea sinensis). Epigallocatechin 3,4-digallate is found in tea.

   

Saprisartan

1-({3-bromo-2-[2-(trifluoromethanesulphonamido)phenyl]-1-benzofuran-5-yl}methyl)-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboximidic acid

C25H22BrF3N4O4S (610.0497)


Saprisartan is an AT1 receptor antagonist. It is based on medications of losartans prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism.(10579749) C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   
   

Epigallocatechin 5,7,-di-O-gallate

(2R,3R) -3,5,7,3,4,5-Hexahydroxyflavan 5,7,-di-O-gallate

C29H22O15 (610.0959)


   

Gallocatechin 7,3-di-O-gallate

(2R,3S) -3,5,7,3,4,5-Hexahydroxyflavan 7,3-di-O-gallate

C29H22O15 (610.0959)


   

Epigallocatechin 3,3,-di-O-gallate

(2R,3R) -3,5,7,3,4,5-Hexahydroxyflavan 3,3,-di-O-gallate

C29H22O15 (610.0959)


   

4,7-Bis(3,4,5-trihydroxybenzoyloxy)-3,3,5,5-tetrahydroxyflavan

4,7-Bis(3,4,5-trihydroxybenzoyloxy)-3,3,5,5-tetrahydroxyflavan

C29H22O15 (610.0959)


   

3,4-Di-O-galloylepicatechin

3,4-Di-O-galloylepicatechin

C29H22O15 (610.0959)


   

5,7-Di-O-galloylepigallocatechin

5,7-Di-O-galloylepigallocatechin

C29H22O15 (610.0959)


   

3,7-Bis(3,4,5-trihydroxybenzoyloxy)-3,4,5,5-tetrahydroxyflavan

3,7-Bis(3,4,5-trihydroxybenzoyloxy)-3,4,5,5-tetrahydroxyflavan

C29H22O15 (610.0959)


   

3,5-Di-O-galloylepigallocatechin

3,5-Di-O-galloylepigallocatechin

C29H22O15 (610.0959)


   

3,3-Di-O-glloylepigallocatechin

3,3-Di-O-glloylepigallocatechin

C29H22O15 (610.0959)


   
   

Epigallocatechin 3,5-Digallate_major

Epigallocatechin 3,5-Digallate_major

C29H22O15 (610.0959)


   

EPIGALLOCATECHIN 3,5-DIGALLATE

EPIGALLOCATECHIN 3,5-DIGALLATE

C29H22O15 (610.0959)


   

Epigallocatechin 3,5,-di-O-gallate

Epigallocatechin 3,5,-di-O-gallate

C29H22O15 (610.0959)


   

Epigallocatechin 3,4,-di-O-gallate

Epigallocatechin 3,4,-di-O-gallate

C29H22O15 (610.0959)


   

Gallocatechin 7,4-di-O-gallate

Gallocatechin 7,4-di-O-gallate

C29H22O15 (610.0959)


   

Saprisartan

1-({3-bromo-2-[2-(trifluoromethane)sulfonamidophenyl]-1-benzofuran-5-yl}methyl)-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide

C25H22BrF3N4O4S (610.0497)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Bis(2-Ethylhexyl) Chlorendate

Bis(2-Ethylhexyl) Chlorendate

C25H36Cl6O4 (610.0745)


   

1H,1H,2H,2H-PERFLUORODECYLTRIETHOXYSILANE

1H,1H,2H,2H-PERFLUORODECYLTRIETHOXYSILANE

C16H19F17O3Si (610.0832)


   
   

UDP-ALPHA-D-GALACTOSE DISODIUM SALT

UDP-ALPHA-D-GALACTOSE DISODIUM SALT

C15H22N2Na2O17P2 (610.0189)


UDP-Galactose disodium is a monosaccharide and a P2Y14 receptor agonist with an EC50 value of 0.67 μM. UDP-Galactose disodium is a substrate for the transferase beta-1, 4 galactosyltransferase V (B4GALT5)[1][2].

   

silicon phthalocyanine dichloride

silicon phthalocyanine dichloride

C32H16Cl2N8Si (610.0644)


   

Uridine 5′-diphosphoglucose disodium salt

Uridine 5′-diphosphoglucose disodium salt

C15H22N2Na2O17P2 (610.0189)


Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[1].

   
   

[(4-Trifluoromethyl)phenyl](2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate

[(4-Trifluoromethyl)phenyl](2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate

C23H22F3IO6S (610.0134)


   

CHLORO ALUMINUM CHLORO PHTHALOYANINE

CHLORO ALUMINUM CHLORO PHTHALOYANINE

C32H17AlCl2N8 (610.0769)


   
   

(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-[(N-acetyl-S-arsono-L-cysteinyl)amino]-2-deoxy-alpha-D-glucopyranoside

(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-[(N-acetyl-S-arsono-L-cysteinyl)amino]-2-deoxy-alpha-D-glucopyranoside

C17H31AsN2O15S (610.0661)


   
   

8-{[9-carboxy-4-(methoxycarbonyl)phenazin-2-yl]sulfanyl}-9-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

8-{[9-carboxy-4-(methoxycarbonyl)phenazin-2-yl]sulfanyl}-9-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C30H18N4O9S (610.0794)


   

2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

5-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

5-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

4-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

4-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

methyl 2-[1-({7,7-dichloro-3-[2-(1,2-dihydroxyethyl)-1,3-thiazole-4-carbonyloxy]-2-methyloctanoyl}oxy)-2-methylpropyl]-1,3-thiazole-4-carboxylate

methyl 2-[1-({7,7-dichloro-3-[2-(1,2-dihydroxyethyl)-1,3-thiazole-4-carbonyloxy]-2-methyloctanoyl}oxy)-2-methylpropyl]-1,3-thiazole-4-carboxylate

C24H32Cl2N2O8S2 (610.0977)


   

2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

(2r,3s)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

(2r,3s)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

4-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

4-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

5-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

5-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)


   

methyl 2-[(1s)-1-{[(2r,3s)-7,7-dichloro-3-{2-[(1r)-1,2-dihydroxyethyl]-1,3-thiazole-4-carbonyloxy}-2-methyloctanoyl]oxy}-2-methylpropyl]-1,3-thiazole-4-carboxylate

methyl 2-[(1s)-1-{[(2r,3s)-7,7-dichloro-3-{2-[(1r)-1,2-dihydroxyethyl]-1,3-thiazole-4-carbonyloxy}-2-methyloctanoyl]oxy}-2-methylpropyl]-1,3-thiazole-4-carboxylate

C24H32Cl2N2O8S2 (610.0977)


   

7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)